Stay updated on Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T22:35:43.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding the effectiveness of relatlimab combined with nivolumab for treating melanoma, while a new version number has been added.
    Difference
    5%
    Check dated 2025-04-16T14:32:13.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 17, 2025. However, the changes do not significantly impact core content or important information.
    Difference
    0.2%
    Check dated 2025-04-09T09:22:37.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.
    Difference
    0.2%
    Check dated 2025-04-01T23:18:26.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The webpage has updated its location listings, adding new locations in Steiermark, Rio Grande Do Sul, Midtjylland, and Yucatán, while removing previous listings for some of these areas. Additionally, there are updates to the estimated last update dates.
    Difference
    7%
    Check dated 2025-03-18T08:51:51.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-24T20:51:25.000Z thumbnail image

Stay in the know with updates to Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.